These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7773504)

  • 1. Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma EPG85-257 cells.
    Seidel A; Hasmann M; Löser R; Bunge A; Schaefer B; Herzig I; Steidtmann K; Dietel M
    Virchows Arch; 1995; 426(3):249-56. PubMed ID: 7773504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
    Toffoli G; Simone F; Gigante M; Boiocchi M
    Biochem Pharmacol; 1994 Nov; 48(10):1871-81. PubMed ID: 7986198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
    Jiang XR; Kelsey SM; Wu YL; Newland AC
    Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucosamine Reverses P-Glycoprotein-Mediated Multidrug Resistance in the Daunorubicin-Resistant Human Gastric Cancer Cells.
    Valinezhad Sani F; Mosaffa F; Jamialahmadi K; Palizban A
    Nutr Cancer; 2020; 72(3):522-527. PubMed ID: 31290701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257.
    Dietel M; Arps H; Lage H; Niendorf A
    Cancer Res; 1990 Sep; 50(18):6100-6. PubMed ID: 1975514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction.
    Ax W; Soldan M; Koch L; Maser E
    Biochem Pharmacol; 2000 Feb; 59(3):293-300. PubMed ID: 10609558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphological and functional features of cytostatic drug resistance and the effects of MDR modulators].
    Reymann A; Bunge A; Läer S; Dietel M
    Pharmazie; 1996 Mar; 51(3):171-6. PubMed ID: 8900868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and modulation of drug transport kinetics in K562 c1.6 daunorubicin-resistant cell line.
    Jiang XR; Macey MG; Collins PW; Newland AC
    Br J Haematol; 1994 Mar; 86(3):547-54. PubMed ID: 8043436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance-associated protein-mediated multidrug resistance modulated by cyclosporin A in a human bladder cancer cell line.
    Kim WJ; Kakehi Y; Hirai M; Arao S; Hiai H; Fukumoto M; Yoshida O
    Jpn J Cancer Res; 1995 Oct; 86(10):969-77. PubMed ID: 7493917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional intracellular P-glycoprotein.
    Shapiro AB; Fox K; Lee P; Yang YD; Ling V
    Int J Cancer; 1998 Jun; 76(6):857-64. PubMed ID: 9626353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.
    Chiodini B; Bassan R; Barbui T
    Leuk Lymphoma; 1999 May; 33(5-6):485-97. PubMed ID: 10342576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes.
    Hurwitz SJ; Terashima M; Mizunuma N; Slapak CA
    Blood; 1997 May; 89(10):3745-54. PubMed ID: 9160680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein pump in leukaemic cells.
    Hegewisch-Becker S; Faltz C; Hossfeld DK
    Eur J Haematol; 1996; 56(1-2):12-22. PubMed ID: 8599988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of intracellular organelles implicated in daunorubicin cytoplasmic sequestration in multidrug-resistant MCF-7 cells using fluorescence microscopy image analysis.
    Bour-Dill C; Gramain MP; Merlin JL; Marchal S; Guillemin F
    Cytometry; 2000 Jan; 39(1):16-25. PubMed ID: 10655559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines.
    Wang B; Wu M; Perchellet EM; McIlvain CJ; Sperfslage BJ; Huang X; Tamura M; Stephany HA; Hua DH; Perchellet JP
    Int J Oncol; 2001 Dec; 19(6):1169-78. PubMed ID: 11713586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined effects of IL-3 and PSC 833 on daunorubicin- and mitoxantrone cytotoxicity in two growth factor-dependent leukemic cell lines.
    Asschert J; de Vries E; van der Kolk D; Müller M; Vellenga E
    Leukemia; 1997 May; 11(5):680-6. PubMed ID: 9180292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Int J Oncol; 1998 Mar; 12(3):711-5. PubMed ID: 9472114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
    Jachez B; Loor F
    Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation.
    Fu D; Roufogalis BD
    Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1543-52. PubMed ID: 17122416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.